These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 7949545

  • 41. Impact of cyclosporine versus tacrolimus on the incidence of de novo malignancy following liver transplantation: a single center experience with 609 patients.
    Wimmer CD, Angele MK, Schwarz B, Pratschke S, Rentsch M, Khandoga A, Guba M, Jauch KW, Bruns C, Graeb C.
    Transpl Int; 2013 Oct; 26(10):999-1006. PubMed ID: 23952102
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Results of the Minnesota randomized prospective trial of cyclosporine versus azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients.
    Sutherland DE, Fryd DS, Strand MH, Canafax DM, Ascher NL, Payne WD, Simmons RL, Najarian JS.
    Am J Kidney Dis; 1985 Jun; 5(6):318-27. PubMed ID: 3893106
    [Abstract] [Full Text] [Related]

  • 45. Extensive prolongation of rat renal allograft survival following donor or nonspecific transfusions and concomitant immunosuppressant.
    Martin DC, Hewitt CW, Black KS, Dowdy SF, Quintero CS, Reyes M.
    Transplantation; 1987 Jun; 43(6):790-4. PubMed ID: 3296345
    [Abstract] [Full Text] [Related]

  • 46. Low incidence of neoplasia in heart and heart-lung transplant recipients receiving triple-drug immunosuppression.
    Olivari MT, Diekmann RA, Kubo SH, Braunlin E, Jamieson SW, Ring WS.
    J Heart Transplant; 1990 Jun; 9(6):618-21. PubMed ID: 2277297
    [Abstract] [Full Text] [Related]

  • 47. Randomized, prospective trial of cyclosporine monotherapy versus azathioprine-prednisone from three months after renal transplantation.
    Hilbrands LB, Hoitsma AJ, Koene KA.
    Transplantation; 1996 Apr 15; 61(7):1038-46. PubMed ID: 8623182
    [Abstract] [Full Text] [Related]

  • 48. A prospective randomized comparison of quadruple versus triple therapy for first cadaver transplants with immediate function.
    Slakey DP, Johnson CP, Callaluce RD, Browne BJ, Zhu YR, Roza AM, Adams MB.
    Transplantation; 1993 Oct 15; 56(4):827-31. PubMed ID: 8212201
    [Abstract] [Full Text] [Related]

  • 49. First and subsequent nonmelanoma skin cancers: incidence and predictors in a population of New Zealand renal transplant recipients.
    Mackenzie KA, Wells JE, Lynn KL, Simcock JW, Robinson BA, Roake JA, Currie MJ.
    Nephrol Dial Transplant; 2010 Jan 15; 25(1):300-6. PubMed ID: 19783601
    [Abstract] [Full Text] [Related]

  • 50. A randomized trial comparing cyclosporine with antilymphoblast-globulin-azathioprine for renal allograft recipients. Results at 2 1/2-6 years.
    Johnson CP, Simmons RL, Sutherland DE, Canafax DM, Ascher NL, Payne WD, Flick B, Najarian JS, Fryd DS.
    Transplantation; 1988 Feb 15; 45(2):380-5. PubMed ID: 3278431
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Subsequent squamous- and basal-cell carcinomas in kidney-transplant recipients after the first skin cancer: cumulative incidence and risk factors.
    Wisgerhof HC, Edelbroek JR, de Fijter JW, Haasnoot GW, Claas FH, Willemze R, Bavinck JN.
    Transplantation; 2010 May 27; 89(10):1231-8. PubMed ID: 20410852
    [Abstract] [Full Text] [Related]

  • 53. Cyclosporine toxicity: the effect of combined therapy using cyclosporine, azathioprine, and prednisone.
    Lorber MI, Flechner SM, Van Buren CT, Sorensen K, Kerman RH, Kahan BD.
    Am J Kidney Dis; 1987 Jun 27; 9(6):476-84. PubMed ID: 3296744
    [Abstract] [Full Text] [Related]

  • 54. Incidence and clinical predictors of a subsequent nonmelanoma skin cancer in solid organ transplant recipients with a first nonmelanoma skin cancer: a multicenter cohort study.
    Tessari G, Naldi L, Boschiero L, Nacchia F, Fior F, Forni A, Rugiu C, Faggian G, Sassi F, Gotti E, Fiocchi R, Talamini G, Girolomoni G.
    Arch Dermatol; 2010 Mar 27; 146(3):294-9. PubMed ID: 20231501
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Outcome of cadaveric renal transplant patients treated for 10 years with cyclosporine: is chronic allograft nephropathy the major cause of late graft loss?
    Marcén R, Pascual J, Teruel JL, Villafruela JJ, Rivera ME, Mampaso F, Burgos FJ, Ortuño J.
    Transplantation; 2001 Jul 15; 72(1):57-62. PubMed ID: 11468535
    [Abstract] [Full Text] [Related]

  • 57. Studies on morphological outcome of cyclosporine-associated arteriolopathy after discontinuation of cyclosporine in renal allografts.
    Morozumi K, Thiel G, Albert FW, Banfi G, Gudat F, Mihatsch MJ.
    Clin Nephrol; 1992 Jul 15; 38(1):1-8. PubMed ID: 1499163
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Effect of cyclosporine A on long-term allograft function in pediatric renal transplant recipients.
    Williams AW, Morgenstern BZ, Murphy M, Milliner DS.
    Pediatr Nephrol; 1994 Oct 15; 8(5):566-9. PubMed ID: 7819002
    [Abstract] [Full Text] [Related]

  • 60. Cancer in renal transplant recipients.
    Sakellariou G, Memmos D, Alexopoulos E, Tsobanelis T, Sinakos Z, Papadimitriou M.
    Cancer Detect Prev; 1986 Oct 15; 9(3-4):389-93. PubMed ID: 3527417
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.